Risk factors for pneumothorax in advanced and/or metastatic soft tissue sarcoma patients during pazopanib treatment: a single-institute analysis
Crossref DOI link: https://doi.org/10.1186/s12885-016-2786-z
Published Online: 2016-09-23
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nakano, Kenji
Motoi, Noriko
Tomomatsu, Junichi
Gokita, Tabu
Ae, Keisuke
Tanizawa, Taisuke
Matsumoto, Seiichi
Takahashi, Shunji
Funding for this research was provided by:
Ministry of Health, Labor and Welfare (201314030C)